The efficacy and safety of Dry needling VS Extracorporeal shockwave therapy for chronic plantar fasciitis treatment, a randomized control trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20140625001

Enrollment

Registered

2014-06-25

Start date

2014-06-25

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heel pain

Interventions

Active Comparator Procedure/Surgery,Experimental Procedure/Surgery

Dry needling,ESWT

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: age more than 18 years old diagnosis of plantar fasciitis by doctor

Exclusion criteria

Exclusion criteria: foot deformity NSAIDs use in 2 wks foot injection in 3 months history of foot surgery underlying disease DM PPN arthritis and hematologic disorder foot ulcer paracetamol allergy pregnancy anticoagulant use

Design outcomes

Primary

Measure	Time frame
Pain VAS	—

Secondary

Measure	Time frame
foot function foot function index	—

Countries

Thailand

Contacts

Public ContactPornsri Trigeewornporn

faculty of medicine

poax236@gmail.com+66815418826

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

The efficacy and safety of Dry needling VS Extracorporeal shockwave therapy for chronic plantar fasciitis treatment&#44; a randomized control trial